Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,753.4 | 134.58 | 4,23,974.49 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,124.4 | 78.02 | 1,61,728.77 | 594 | 0.49 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,436.6 | 25.14 | 1,16,999.05 | 1,438.15 | 0.9 | 4,134.87 | 360.73 |
Mankind Pharma Ltd MANKIND | 2,483.15 | 54.43 | 1,05,258.19 | 416.38 | 0 | 2,396.57 | 334.18 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,115.7 | 57.61 | 1,05,084.28 | 485 | 0.9 | 2,330 | 222.38 |
No Record Found
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
